Project Background
A drug discovery client had developed a BRD4-targeting degrader using a validated bromodomain warhead and a cereblon ligand. Although the initial compound showed measurable target engagement, degradation performance plateaued at moderate levels and varied substantially across cell lines. The client suspected that linker geometry, rather than either binding moiety, was limiting productive ternary complex formation and engaged BOC Sciences for a focused linker optimization campaign.
Technical Challenges
The original linker series relied heavily on flexible PEG-like spacers, which improved solubility but introduced conformational heterogeneity. Early profiling suggested that binary binding remained acceptable, yet degradation depth and consistency were not sufficient for lead nomination. The client needed a clearer understanding of how linker rigidity, length, and attachment pattern affected functional output.
BOC Sciences Solutions
- Linker Series Expansion: We designed 24 linker variants across flexible, semi-rigid, and hybrid chemotypes, including alkyl-ether, constrained aryl-containing, and heterocycle-interrupted motifs.
- Exit Vector Reassessment: We re-evaluated the attachment geometry on the BRD4 warhead and prioritized two alternative connection positions to improve spatial presentation toward the ligase ligand.
- Integrated Functional Ranking: Compounds were ranked using combined analytical profiling, ternary complex assessment, and cellular degradation data rather than property screening alone.
Project Outcomes
The final lead linker was a semi-rigid hybrid architecture that reduced conformational excess while maintaining workable polarity. Across the 24 designed analogues, BOC Sciences identified 5 clear advancement candidates and one best-in-class linker motif that improved degradation depth from approximately 55% to over 85% in the client's primary cellular assay. The optimized design also delivered more consistent activity across multiple BRD4-relevant models, giving the client a more reliable degrader series for subsequent development.
Project Background
A biotechnology company was advancing a kinase-targeting PROTAC built on a potent warhead and a VHL ligand. The degrader displayed encouraging biochemical performance but suffered from poor apparent solubility and unstable exposure in downstream assay media, which reduced the interpretability of biological results. The client requested a linker redesign program that could improve molecular balance without losing degradation activity.
Technical Challenges
The original linker was highly lipophilic and overextended the overall molecule, leading to aggregation tendency, inconsistent analytical recovery, and reduced cellular robustness. Straightforward polarity increases were expected to risk loss of permeability or distort the productive target-ligase orientation.
BOC Sciences Solutions
- Property-Oriented Redesign: We generated 18 new linker analogues incorporating polarity-modulating heteroatoms, shortened span length, and limited conformational constraint where necessary.
- Comparative Stability Analysis: Each analogue was profiled for solution behavior and assay-relevant stability to identify chemotypes that improved practical developability rather than theoretical property scores alone.
- Mechanism-Aware Prioritization: We selected candidate linkers that balanced molecular compactness with the geometry required for productive VHL-mediated degradation.
Project Outcomes
From the 18 synthesized analogues, BOC Sciences narrowed the series to 4 high-value candidates and identified one optimized linker that delivered markedly improved assay consistency and substantially stronger cellular degradation relative to the starting structure. The lead molecule showed a clearer balance of stability, exposure, and degradation behavior, enabling the client to progress with a more developable kinase degrader framework and a stronger SAR rationale for future rounds.
Ternary Complex Productivity
